Bioelectronics Corp (BIEL)

[Simpsonly]

Not bad at all Steve - Andrew Whelan stays on as Chair, he’s earned that, deserves that, put his all into BIEL.....AND retains a huge wealth of knowledge. He’s a very bright guy and the company would benefit greatly with him as Chair. Put in a new President and CEO, from TEVA/ANDA (we don’t, or may not, know all the details of those relationships yet), or elsewhere, and BIEL emerges a better and more powerful company. But Whelan must stay because of his value. With BIEL’s IP, FDA OTC clearances and the TEVA/ANDA USA distribution deal, I say we then have a very well managed powerhouse with patented disruptive technology in the massive pain management field. Good corporate governance does not involve radical or major changes; BIEL has good bones, just needs a little tweaking here and there and not all at once. You know when.....